Navidea Biopharmaceuticals, Inc.
NAVBDelisted Jan 16, 2024- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000810509
Navidea Biopharmaceuticals, Inc. was delisted on Jan 16, 2024; its insiders filed their last Form 4 on Dec 5, 2023; 24 institutions reported holding it in 13F filings for Q3 2023, worth $225.8K in total; no superinvestor held it.
Q2 2021 vs. Q1 2021
How the institutions holding Navidea Biopharmaceuticals, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 35 | 31 | −4 |
| Shares | 1.87M | 1.68M | −186.4K (−10.0%) |
| Value | $3.77M | $3.08M | −$696.5K (−18.5%) |
New holders (4)
Institutions that held Navidea Biopharmaceuticals, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| State Street Corp | 23,843 | $44.0K | 0.00% |
| Simplex Trading, LLC | 13,179 | $24.0K | 0.00% |
| Advisory Services Network, LLC | 250 | $0 | 0.00% |
| Center for Financial Planning, Inc. | 9 | $0 | 0.00% |
Sold out (8)
Institutions that held Navidea Biopharmaceuticals, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Renaissance Technologies LLC | 131,618 | $266.0K |
| Squarepoint Ops LLC | 28,836 | $58.0K |
| California Public Employees Retirement System | 18,385 | $37.0K |
| Wolverine Trading, LLC | 11,219 | $22.0K |
| Sowell Financial Services LLC | 11,190 | $18.0K |
| Tower Research Capital LLC (TRC) | 783 | $2.00K |
| Bank of Montreal | 160 | $0 |
| O'Shaughnessy Asset Management, LLC | 141 | $0 |